Elm Advisors’s Exact Sciences EXAS Stock Holding History

Elm Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-450	Closed	-$60K	–	152
2020 Q4	$60K	Buy	+450	New	+$54.4K	0.04%	153

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Elm Advisors's EXAS Position: Q1 2021 in Review

Elm Advisors sold out of Exact Sciences (EXAS) in Q1 2021, closing a stake of 450 shares — an estimated $60K sold.

Elm Advisors first reported a position in EXAS in Q4 2020 and held it in 1 quarter. The position peaked at $60K in Q4 2020. 645 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

Elm Advisors reported no remaining Exact Sciences position as of Q1 2021 after selling out during the quarter.
Elm Advisors sold 450 Exact Sciences shares in Q1 2021, an estimated $60K.
Elm Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 1 quarter.
Elm Advisors's Exact Sciences position peaked at $60K in Q4 2020.
645 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on Elm Advisors's 13F filing for Q1 2021, filed 5 Apr 2021.